<bill session="118" type="h" number="133" updated="2025-05-27T14:14:48Z">
  <state datetime="2023-12-06">REPORTED</state>
  <status>
    <unknown datetime="2023-12-06"/>
  </status>
  <introduced datetime="2023-01-09"/>
  <titles>
    <title type="display">MERIT Act</title>
    <title type="short" as="introduced">Mandating Exclusive Review of Individual Treatments (MERIT) Act</title>
    <title type="short" as="reported to house">Mandating Exclusive Review of Individual Treatments Act</title>
    <title type="short" as="reported to house">MERIT Act</title>
    <title type="official" as="introduced">To amend title XVIII of the Social Security Act to clarify the use of the national coverage determination process under the Medicare program.</title>
  </titles>
  <sponsor bioguide_id="B001260"/>
  <cosponsors>
    <cosponsor bioguide_id="B001300" joined="2023-01-09"/>
    <cosponsor bioguide_id="C001126" joined="2023-05-11"/>
    <cosponsor bioguide_id="F000465" joined="2023-05-10"/>
    <cosponsor bioguide_id="F000466" joined="2023-05-09"/>
    <cosponsor bioguide_id="M001205" joined="2023-08-25"/>
    <cosponsor bioguide_id="S000168" joined="2023-01-09"/>
  </cosponsors>
  <actions>
    <action datetime="2023-01-09">
      <text>Introduced in House</text>
    </action>
    <action datetime="2023-01-09" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2023-01-09">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2023-01-20">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2023-11-15">
      <text>Subcommittee Consideration and Mark-up Session Held</text>
    </action>
    <action datetime="2023-11-15">
      <text>Forwarded by Subcommittee to Full Committee in the Nature of a Substitute (Amended) by Voice Vote.</text>
    </action>
    <action datetime="2023-12-05">
      <text>Committee Consideration and Mark-up Session Held</text>
    </action>
    <action datetime="2023-12-06">
      <text>Committee Consideration and Mark-up Session Held</text>
    </action>
    <action datetime="2023-12-06" state="REPORTED">
      <text>Ordered to be Reported (Amended) by the Yeas and Nays: 42 - 0.</text>
    </action>
    <action datetime="2024-11-22">
      <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-764, Part I.</text>
    </action>
    <action datetime="2024-11-22">
      <text>House Committee on Ways and Means Granted an extension for further consideration ending not later than Dec. 19, 2024.</text>
    </action>
    <action datetime="2024-12-17">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2024-12-19">
      <text>Committee on Ways and Means discharged.</text>
    </action>
    <calendar datetime="2024-12-19" calendar="Union" number="779">
      <text>Placed on the Union Calendar, Calendar No. 779.</text>
    </calendar>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Discharged From, Unknown, Referred To"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Reported By, Markup By, Markup By, Referred To"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Reporting, Markup, Referral"/>
    <committee code="HSIF16" name="House Energy and Commerce" subcommittee="Communications and Technology" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Medical research"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2023-02-09T22:15:40Z" status="Introduced in House">Mandating Exclusive Review of Individual Treatments (MERIT) Act

This bill specifies that coverage determinations for drugs and biologics under Medicare must be made with respect to each drug or biologic, rather than with respect to a class of drugs or biologics.</summary>
  <committee-reports>
    <report>H. Rept. 118-764</report>
  </committee-reports>
</bill>
